1053634-79-9

Upstream product

• 203063-24-5 (S)-5-((R)-(R)-1,4-Dioxa-spiro[4.5]dec-2-yl-triethylsilanyloxy-methyl)-4-methoxy-3-methyl-5H-furan-2-one 
• 203063-26-7 (3R,4S,5R)-5-((R)-(R)-1,4-Dioxa-spiro[4.5]dec-2-yl-triethylsilanyloxy-methyl)-4-methoxy-3-methyl-dihydro-furan-2-one 
• 203063-27-8 (3R,4S,5S)-5-((R)-(R)-1,4-Dioxa-spiro[4.5]dec-2-yl-hydroxy-methyl)-4-methoxy-3-methyl-dihydro-furan-2-one 
• 78008-36-3 (R)-2,3-cyclohexylideneglyceraldehyde 
• 27205-80-7 4-methoxy-3-methyl-2(5H)-furanone 

Downstream Products

• 203063-33-6 Acetic acid (1R,2S,3S)-4-(tert-butyl-diphenyl-silanyloxy)-1-((R)-(R)-1,4-dioxa-spiro[4.5]dec-2-yl-methanesulfonyloxy-methyl)-2-methoxy-3-methyl-butyl ester 

Relevant academic research and scientific papers

Stereoselective construction of the key intermediate for the synthesis of the tetrahydropyranyl antifungal agents (+)-restricticin and (+)-lanomycin

Stereoselective construction of the key intermediate for the synthesis of naturally occurring antifungal agents, such as (+)-restricticin and (+)-lanomycin, has been achieved by employing a chelation-controlled aldol reaction of methyl α-methyltetronate w